Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 50,750,979 |
|
|||||
| News | - | ||||||
| Day High | 0.0012 | Low High |
|||||
| Day Low | 0.0007 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Propanc Biopharma Inc (PK) | PPCB | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.00034 | -29.82% | 0.0008 | 15:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.0012 | 0.0007 | 0.0012 | 0.0008 | 0.00114 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 113 | 50,750,979 | US$ 0.000866 | US$ 43,955 | - | 0.0006 - 0.2625 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:01:00 | average | 6,007,000 | US$ 0.00083 | USD |
Propanc Biopharma Inc (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 4.14M | - | 0 | -3.13M | -0.00 | 0.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Propanc Biopharma (PK) News
Real-Time news about Propanc Biopharma Inc (PK) (OTCMarkets): 0 recent articles
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PPCB Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.0009 | 0.0013 | 0.0006 | 0.0009627 | 18,131,291 | -0.0001 | -11.11% |
| 1 Month | 0.0011 | 0.0015 | 0.0006 | 0.0009497 | 9,886,817 | -0.0003 | -27.27% |
| 3 Months | 0.0042 | 0.0048 | 0.0006 | 0.0017034 | 6,880,617 | -0.0034 | -80.95% |
| 6 Months | 0.0096 | 0.02 | 0.0006 | 0.0033355 | 4,233,890 | -0.0088 | -91.67% |
| 1 Year | 0.20 | 0.2625 | 0.0006 | 0.0152626 | 2,687,337 | -0.1992 | -99.60% |
| 3 Years | 100.00 | 148.05 | 0.0006 | 1.61 | 16,856,112 | -100.00 | -100.00% |
| 5 Years | 6.50 | 2,570.00 | 0.0006 | 2.53 | 12,631,213 | -6.50 | -99.99% |
Propanc Biopharma (PK) Description
| Propanc Biopharma, Inc. is developing a novel approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from solid tumors, such as pancreatic, ovarian and colorectal cancers. The Company's novel proenzyme therapy is based on the science that enzymes stimulate biological reactions in the body, especially enzymes secreted by the pancreas. These pancreatic enzymes could represent the body's primary defense against cancer. |
